Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Feb 2025 for CUTERA INC, €251.
Filing timeline
BuySaleStephana Eilene Patton
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -5.3%Entry US$2.30 · Close at T+365 US$2.18
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephana Eilene Patton: trading record in brief
Stephana Eilene Patton is a declared insider at 3 companies; the most frequent names are Cutera Inc, Lineage Cell Therapeutics, Inc. and Eiger BioPharmaceuticals, Inc. The record holds 13 filings, for trades running from 21 August 2017 to 13 February 2025.
On the market, this insider has only ever bought: 2 purchases, €26k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 9 share grants and 2 option exercises.
The latest filing, published on 21 February 2025, reports a share grant of €251 in Cutera Inc. The last insider purchase was made public on 22 April 2019, 2,741 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stephana Eilene Patton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
623 shares@ US$0.418625.8% of flowCOMMON STOCKSEC:0001628280-25-007066:0
2,161 shares@ US$0.355174.2% of flowCOMMON STOCKSEC:0001628280-24-048102:0
25,000 shares0COMMON STOCKSEC:0001628280-24-010056:1
30,000 shares0COMMON STOCKSEC:0001628280-24-010056:2
25,000 shares0COMMON STOCKSEC:0001628280-24-010056:0
11,875 shares0Common StockSEC:0001209191-21-020591:0
820 shares@ US$7.31100.0% of flowCommon StockSEC:0001209191-20-018995:0
1,000 shares@ US$11.0364.5% of flowCommon StockSEC:0001209191-19-025562:0
Canonical exit: 21 Jul 2019 (T+90)
9,510 shares@ US$1.0348.5% of flowCommon Shares, no par valueSEC:0001209191-18-063602:1
27,500 shares0Common Shares, no par valueSEC:0001209191-18-063602:0
13,750 shares0Common Shares, no par valueSEC:0001209191-18-054593:0
4,755 shares@ US$2.2251.5% of flowCommon Shares, no par valueSEC:0001209191-18-054593:1
7,500 shares@ US$2.5847.9% of flowCommon Shares, no par valueSEC:0001209191-17-049882:0
Canonical exit: 19 Nov 2017 (T+90)
13 of 13 declarations
